BIOE Seminar Series: Anand Subramony

Friday, March 31, 2017
9:00 a.m.-10:00 a.m.
Pepco Room (1105), Jeong H. Kim Engineering Building
Dr. John P. Fisher

Anand Subramony
Vice President Drug Delivery & Device Development

Enabling patient centric therapies through drug delivery 

Drug delivery and devices technologies will transform how patients manage their health in the near future. As personalized health care strategies, companion diagnostics, and connected health are becoming more advanced, pharmaceutical and biotech companies are  shifting to a “patient outcome”, or ‘pay for value’ based mode than selling a pill or an injection. Pharma models are therefore evolving towards creating total drug product solutions for patients rather than simply acting as a provider of dosage forms. Drug product development through novel delivery and connected health technologies plays an important role in this new paradigm. The emergence of biologics therapeutics have led to the need for novel  patient centric devices for parenteral delivery. In this talk, drug delivery devices for antibodies in the area respiratory diseases will be discussed

Audience: Public 


November 2018

28 29 30 31 1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 1
Submit an Event